On Jan. 17, Barclays PLC (BCS) reduced its price target for Keurig Dr Pepper to $36 from $39, while maintaining an “Overweight” rating on the stock. The analyst noted, "It feels like there ...

Piper Sandler started coverage on Keurig Dr Pepper in a report on Tuesday, January 7th. They issued a “neutral” rating and a $35.00 price objective for the company. Finally, Barclays cut their ...

Keurig Dr Pepper has introduced several new flavors to its 2025 U.S. beverage lineup. Dr Pepper Blackberry, 7UP Tropical, ...

Keurig Dr Pepper Inc. (NASDAQ ... On January 17, Lauren Lieberman, analyst at Barclays maintained a Buy rating on the stock, while keeping the price target of $36. Oakmark Select Fund in its ...

It is hard to get excited after looking at Keurig Dr Pepper's (NASDAQ:KDP) recent performance, when its stock has declined 6.0% over the past three months. But if you pay close attention ...